• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过氨基比林呼吸试验评估肝功能。

Assessment of liver function by the aminopyrine breath test.

作者信息

Villeneuve J P, Arsène D, Huet P M

出版信息

Clin Invest Med. 1983;6(1):5-9.

PMID:6403268
Abstract

The aminopyrine breath-test (ABT) has been proposed as a non-invasive quantitative test of liver function and reserve. To evaluate its usefulness, we compared the ABT with standard liver function tests, Child's classification of liver disease and ICG clearance, as means of assessing liver function in 30 patients with cirrhosis. The cumulative output of 14CO2 in breath during the 6 h following [14C]aminopyrine administration was significantly decreased in the cirrhotic group as compared with control subjects. The severity of liver dysfunction, as assessed by Child's classification, was associated with a progressive and statistically significant impairment of the ABT. There was a good correlation between the ABT and ICG systemic clearance (r = 0.770, P less than 0.001) and also between the ABT and ICG intrinsic clearance (r = 0.885, P less than 0.001), a measure which is independent of hepatic blood flow variations. These results further strengthen the concept that the ABT is a simple non-invasive method to assess quantitatively liver function and reserve, and could be useful in following the evolution of patients with liver disease.

摘要

氨基比林呼吸试验(ABT)已被提议作为一种肝功能及储备功能的非侵入性定量检测方法。为评估其效用,我们将ABT与标准肝功能检测、Child肝病分级以及吲哚氰绿(ICG)清除率进行了比较,以此作为评估30例肝硬化患者肝功能的手段。与对照组相比,肝硬化组在给予[14C]氨基比林后6小时内呼出气体中14CO2的累积排出量显著降低。根据Child分级评估的肝功能障碍严重程度与ABT的进行性且具有统计学意义的损害相关。ABT与ICG全身清除率之间存在良好的相关性(r = 0.770,P < 0.001),ABT与ICG固有清除率之间也存在良好相关性(r = 0.885,P < 0.001),后者是一种独立于肝血流变化的指标。这些结果进一步强化了这样一种观念,即ABT是一种评估肝功能及储备功能的简单非侵入性方法,并且可能有助于追踪肝病患者的病情进展。

相似文献

1
Assessment of liver function by the aminopyrine breath test.通过氨基比林呼吸试验评估肝功能。
Clin Invest Med. 1983;6(1):5-9.
2
Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.肝硬化患者的尿钠平衡:与肝功能定量参数的关系
Hepatology. 1997 Nov;26(5):1149-55. doi: 10.1002/hep.510260510.
3
[Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].[肝脏疾病中药物代谢酶系统的定量分析:安替比林唾液清除率与氨基比林呼吸试验的比较]
Schweiz Med Wochenschr. 1985 May 11;115(19):651-8.
4
Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.氨基比林呼气试验:一种用于人体肝功能定量评估的13C呼气试验的开发。
Hepatogastroenterology. 1995 Nov-Dec;42(6):931-8.
5
A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.一种用于常规测定肝脏代谢能力的简单方法:氨基比林呼气试验。
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23(4):190-6.
6
The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.氨基比林呼气试验与肝硬化患者肝脏疾病严重程度的关系。
Am J Gastroenterol. 1981 Aug;76(2):110-3.
7
Relationship of the aminopyrine breath test and the Child-Pugh score to urinary sodium retention in patients with liver cirrhosis.
Z Gastroenterol. 1995 Mar;33(3):150-4.
8
13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.正常受试者和肝硬化患者口服13C-氨基比林后呼出气体中13CO2的排泄。与MEGX试验在慢性肝炎和肝硬化功能鉴别中的比较。
Hepatogastroenterology. 2000 Jan-Feb;47(31):234-8.
9
Effects of transjugular intrahepatic portosystemic shunt (TIPS) on quantitative liver function tests.经颈静脉肝内门体分流术(TIPS)对定量肝功能试验的影响。
Hepatogastroenterology. 1998 Nov-Dec;45(24):2315-21.
10
Noninvasive diagnosis and prognosis of liver cirrhosis: a comparison of biological scores, elastometry, and metabolic liver function tests.非侵入性诊断和肝硬化预后:生物标志物评分、弹性成像和代谢肝功能检测的比较。
Eur J Gastroenterol Hepatol. 2010 May;22(5):532-40. doi: 10.1097/MEG.0b013e3283343f58.

引用本文的文献

1
Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.使用有限采样程序估算非那宗(安替比林)药代动力学参数以识别肝药物代谢受损患者。
Clin Pharmacokinet. 1993 Apr;24(4):333-43. doi: 10.2165/00003088-199324040-00006.
2
Drug disposition in patients with HBsAg-positive chronic liver disease.
Dig Dis Sci. 1987 Jul;32(7):710-4. doi: 10.1007/BF01296136.